ACAT1 and atherosclerosis: Interestingly, pactimibe (ACAT inhibitor) had no effect on atherosclerosis as assessed by changes in maximum carotid intima-media thickness (CIMT) compared with placebo but was actually associated with an increase in mean CIMT as well as increased incidence of major cardiovascular events (Meuwese et al., 2009).